These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19849740)

  • 1. Vaccination and screening for infections in patients with inflammatory bowel disease: a survey of Australian gastroenterologists.
    Gupta A; Macrae FA; Gibson PR
    Intern Med J; 2011 Jun; 41(6):462-7. PubMed ID: 19849740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease.
    Walsh AJ; Weltman M; Burger D; Vivekanandarajah S; Connor S; Howlett M; Radford-Smith G; Selby W; Veillard AS; Grimm MC; Travis SP; Lawrance IC
    J Crohns Colitis; 2013 Nov; 7(10):e449-56. PubMed ID: 23601754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease.
    Theis VS; Rhodes JM
    Aliment Pharmacol Ther; 2008 Jan; 27(1):19-30. PubMed ID: 17944997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of Immunization Practices in Patients With Inflammatory Bowel Disease Among Pediatric Gastroenterologists.
    Lester R; Lu Y; Tung J
    J Pediatr Gastroenterol Nutr; 2015 Jul; 61(1):47-51. PubMed ID: 25611033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical guidelines for treating inflammatory bowel disease safely with anti-tumour necrosis factor therapy in Australia.
    Connell W; Andrews JM; Brown S; Sparrow M
    Intern Med J; 2010 Feb; 40(2):139-49. PubMed ID: 20446955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis and tumour necrosis factor-alpha inhibitor therapy: a report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians.
    Perlmutter A; Mittal A; Menter A
    Br J Dermatol; 2009 Jan; 160(1):8-15. PubMed ID: 19016693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for opportunistic infections and vaccination before introduction of biologic therapy].
    Sincić BM; Vince A
    Acta Med Croatica; 2013 Apr; 67(2):165-70. PubMed ID: 24471299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insufficient awareness and vaccination practices for inflammatory bowel disease patients in China: A multi-center survey of Chinese gastroenterologists.
    Li SY; Li PW; Shen B; Zhi M; Gu YB; Wang XY; Guo H; Li Y; Fan YH; Yang BL; Xue M; Wang XY; Lv MF; Li Y; Ye B; Zhu XJ; Chen Y
    J Dig Dis; 2020 Jan; 21(1):46-51. PubMed ID: 31794121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Global Survey of Gastroenterologists' Travel Advice to Patients with Inflammatory Bowel Disease on Immunosuppressive Agents and Management of Those Visiting Tuberculosis-Endemic Areas.
    Chan W; Shim HH; Ng SC; ; Liu J; Inglis C; Greveson K; Baraty B; Haifer C; Leong RWL
    J Crohns Colitis; 2018 Nov; 12(11):1261-1269. PubMed ID: 30215692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
    Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
    Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for hepatitis B in chemotherapy patients: survey of current oncology practices.
    Tran TT; Rakoski MO; Martin P; Poordad F
    Aliment Pharmacol Ther; 2010 Jan; 31(2):240-6. PubMed ID: 19814747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis.
    Viget N; Vernier-Massouille G; Salmon-Ceron D; Yazdanpanah Y; Colombel JF
    Gut; 2008 Apr; 57(4):549-58. PubMed ID: 18178610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease.
    Shale MJ
    Br Med Bull; 2009; 92():61-77. PubMed ID: 19855102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory therapy for pediatric inflammatory bowel disease: changing patterns of use, 1990-2000.
    Markowitz J; Grancher K; Kohn N; Daum F
    Am J Gastroenterol; 2002 Apr; 97(4):928-32. PubMed ID: 12003428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns.
    Schroy PC; Barrison AF; Ling BS; Wilson S; Geller AC
    Am J Gastroenterol; 2002 Apr; 97(4):1031-6. PubMed ID: 12008667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in India -- An audit report.
    Malaviya AN; Kapoor S; Garg S; Rawat R; Shankar S; Nagpal S; Khanna D; Furst DE
    J Rheumatol; 2009 Jul; 36(7):1414-20. PubMed ID: 19487263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening colonoscopy and fecal occult blood testing practice patterns: a population-based survey of gastroenterologists.
    Rossi F; Sosa JA; Aslanian HR
    J Clin Gastroenterol; 2008; 42(10):1089-94. PubMed ID: 18936643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy.
    Stine JG; Khokhar OS; Charalambopoulos J; Shanmugam VK; Lewis JH
    Arthritis Care Res (Hoboken); 2010 May; 62(5):704-11. PubMed ID: 20461789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.